CIHR – Catalyst Grant – NWHRI: Innovation Fund – Biomedical Discovery Grants – Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: Friday 14th, July 2023
External Deadline: Wednesday 19th, July 2023
Description
The purpose of the National Women’s Health Research Initiative, a joint initiative between CIHR and Women and Gender Equality Canada announced as part of the 2021 federal budget, is to advance a coordinated research program that addresses under-researched and high-priority areas of women’s health. The National Women’s Health Research Initiative will help to ensure new evidence improves women’s, girls’, and gender-diverse people’s care and health outcomes.
The National Women’s Health Research Initiative is composed of two funding streams: The Pan-Canadian Women’s Health Coalition and the Innovation Fund. Two funding opportunities will be launched through the Innovation Fund to support research in areas of women’s health that have been chronically underfunded and under-researched. The first Innovation Fund funding opportunity consists of one-year Biomedical Discovery Grants (this current funding opportunity). The second funding opportunity (to be launched later in 2023) will consist of operating grants to support three-year research projects in two areas of women’s health: 1) translational research in healthcare diagnostics, therapeutics, and devices; and 2) healthcare implementation research to remove barriers to accessing healthcare.
The overarching vision of this Biomedical Discovery Grant funding opportunity is to support “high risk, high reward” research in high-priority areas of women’s health research. This funding opportunity will support basic science and/or other types of preclinical studies that have the potential to make significant advancements in women’s health. Projects are expected to involve cells, tissues, body parts, and/or biomarkers. Studies focused on female technology (Femtech) are also eligible.
Research Areas
This funding opportunity encourages projects in specific areas that have been chronically underfunded and under-researched. These areas include, but are not limited to:
- Diagnosis and treatment of endometriosis
- Early detection of ovarian cancer
- Early self-detection of breast cancer
- Treatment for gynecologic conditions, including fibroids, polycystic ovary syndrome and/or pelvic floor dysfunction
- Treatment for perimenopausal, menopausal and postmenopausal symptoms in cases where hormone therapy may not be suitable or desired
- Development of non-hormonal female contraceptives
- Gender-affirming hormone therapies
Important Dates
| Competition | 202307NWI |
|---|---|
| Registration Deadline | 2023-06-21 |
| Application Deadline | 2023-07-19 |
| Anticipated Notice of Decision | 2024-01-30 |
| Funding Start Date | 2024-02-01 |
More details can be found on ResearchNet, here.